Australia markets closed

Genetic Signatures Limited (GSS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.7000+0.0050 (+0.72%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 129.61M
Enterprise value 111.49M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.94
Price/book (mrq)3.20
Enterprise value/revenue 7.66
Enterprise value/EBITDA -6.31

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 37.00%
S&P500 52-week change 323.10%
52-week high 30.7500
52-week low 30.3800
50-day moving average 30.6504
200-day moving average 30.5301

Share statistics

Avg vol (3-month) 3124.32k
Avg vol (10-day) 358.24k
Shares outstanding 5186.48M
Implied shares outstanding 6168.48M
Float 8125.18M
% held by insiders 127.92%
% held by institutions 135.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -112.83%
Operating margin (ttm)-211.98%

Management effectiveness

Return on assets (ttm)-23.50%
Return on equity (ttm)-40.28%

Income statement

Revenue (ttm)15.99M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)-51.60%
Gross profit (ttm)N/A
EBITDA -16.83M
Net income avi to common (ttm)-18.04M
Diluted EPS (ttm)-0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.12M
Total cash per share (mrq)0.13
Total debt (mrq)12k
Total debt/equity (mrq)0.03%
Current ratio (mrq)8.06
Book value per share (mrq)0.28

Cash flow statement

Operating cash flow (ttm)-9.6M
Levered free cash flow (ttm)-13.58M